Dimensional Fund Advisors LP Sells 39,289 Shares of Ingevity Co. (NYSE:NGVT)

Dimensional Fund Advisors LP lowered its holdings in Ingevity Co. (NYSE:NGVT - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 793,423 shares of the company's stock after selling 39,289 shares during the period. Dimensional Fund Advisors LP owned about 2.18% of Ingevity worth $32,331,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of NGVT. American Century Companies Inc. grew its position in Ingevity by 37.7% during the fourth quarter. American Century Companies Inc. now owns 1,457,365 shares of the company's stock valued at $59,388,000 after buying an additional 398,800 shares during the period. Royce & Associates LP grew its position in shares of Ingevity by 22.4% during the 4th quarter. Royce & Associates LP now owns 1,142,598 shares of the company's stock valued at $46,561,000 after acquiring an additional 208,921 shares during the period. KLP Kapitalforvaltning AS bought a new stake in shares of Ingevity in the 4th quarter worth approximately $4,882,000. Wellington Management Group LLP lifted its stake in Ingevity by 5.4% in the fourth quarter. Wellington Management Group LLP now owns 2,239,970 shares of the company's stock valued at $91,279,000 after purchasing an additional 115,581 shares during the last quarter. Finally, Segall Bryant & Hamill LLC grew its holdings in Ingevity by 8.6% during the fourth quarter. Segall Bryant & Hamill LLC now owns 1,287,281 shares of the company's stock valued at $52,457,000 after purchasing an additional 101,866 shares during the period. Institutional investors own 91.59% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. BMO Capital Markets raised Ingevity from a "market perform" rating to an "outperform" rating and upped their price target for the company from $62.00 to $65.00 in a research report on Wednesday, February 26th. StockNews.com lowered Ingevity from a "buy" rating to a "hold" rating in a research note on Saturday, April 12th. Finally, Wells Fargo & Company cut their price objective on shares of Ingevity from $45.00 to $32.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $52.20.

Ingevity Stock Performance

Shares of NGVT opened at $35.40 on Tuesday. Ingevity Co. has a 12-month low of $28.49 and a 12-month high of $56.28. The company has a market cap of $1.29 billion, a PE ratio of -2.99 and a beta of 1.31. The company has a current ratio of 1.87, a quick ratio of 1.04 and a debt-to-equity ratio of 6.86. The stock has a 50-day moving average price of $38.27 and a 200-day moving average price of $41.76.

Ingevity (NYSE:NGVT - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.25. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The business's quarterly revenue was down 16.5% on a year-over-year basis. During the same quarter last year, the company earned $0.47 earnings per share. As a group, equities analysts forecast that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Co. (NYSE:NGVT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.